Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: content day coming
Webinar: Characteristics of Recent PRO Labeling by the FDA and EMA for Oncology Drugs Share on: Wednesday, March 13 - Thursday, March 14, 2019 Watch the Recording Trends in EMA and FDA Labeling Based on Patient-Reported Outcomes (PROs) A recent review of …
Webinar: The End of Significance Testing Share on: Thursday, March 28, 2019, 10 - 11am Watch the recording The use of statistical significance testing in epidemiological research Null hypothesis significance testing is not dead, but in this webinar, Ken …
Determining Effectiveness of Risk-Minimization Measures Impact of Risk Minimization Measures on the Use of Cilostazol in Europe J Castellsague, B Calingaert , B Poblador-Plou, M Giner-Soriano, M Linder, O Scholle, A Arana Navarro, C Bui , C Laguna, A …
Webinar: Strategic Planning for Orphan Drugs Share on: Tuesday, June 7, 2022, 10 - 11am Maximizing Asset Value Through Evidence Generation Planning When developing new products to treat rare diseases, it is particularly challenging to demonstrate …
ISPOR Europe 2022 Vienna Share on: Sunday, November 6 - Wednesday, November 9, 2022 Conference Website Image If you are looking for ISPOREU 2023, click here. We're looking forward to seeing you live and in person at ISPOR in Vienna! We invite you to stop …
How are United States ICER'S Evidence Ratings Determined? You can read the related research here: How are United States ICER'S evidence ratings determined?: A systematic review of ICER'S evidence ratings in evidence reports for new drugs in 2020 and 2021. …
64th ASH Annual Meeting & Exposition Share on: Saturday, December 10 - Tuesday, December 13, 2022 Conference Website Research coauthored by RTI Health Solutions researchers will be presented at the 64th ASH Annual Meeting & Exposition. Fitusiran reaches …
In-Person Course: Regulatory-Grade Causal Inference in Health Research Share on: Wednesday, March 12, 2025, 3pm - Friday, March 14, 2025, 1pm Learn to Use Target Trial Emulation for Regulatory Real-World Evidence Generation Presented by RTI Health …
Hematology A Wealth of Experience We have collaborated with our clients on projects to research hematology, hematologic treatments, and complications and comorbidities of hematologic diseases. Our experience includes: Allogeneic cord blood therapy Anemia …
Ophthalmology A Wealth of Experience We have collaborated with our clients on projects to research ocular disease, ocular treatment, and complications and comorbidities of ocular disease. Our experience includes: Benign essential blepharospasm (BEB) …